Presentation CDM 2017 Cardiopulmonary Arrest: Therapeutic Hypothermia and Compression Only CPR Presenter: Jason Bartos October 05, 2017
Presentation CDM 2017 Can CHD and DM be Prevented? The Answer is on Your Plate Presenter: Robert A. Vogel October 05, 2017
Presentation CDM 2017 Primary Aldosteronism & Implications for Primary Hypertension Presenter: Richard J. Auchus October 05, 2017
Presentation Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve September 27, 2017
Presentation VIVA 2017 What is the Right Antiplatelet Therapy for Symptomatic Carotid Disease? Presenter: William Gray September 21, 2017
Presentation VIVA 2017 Is Aspirin Really a Class I Medication in Peripheral Artery Disease? Presenter: Ehrin J. Armstrong September 19, 2017
Presentation Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair September 16, 2017
Presentation Global Geographic Variation in Patient Characteristics in PCI Clinical Trials September 15, 2017
Presentation iASSESS 2017 Radial Access and Related Complications Presenter: Jordan Safirstein August 30, 2017
Presentation ESC 2017 Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China Presenter: Anselm K. Gitt August 30, 2017
Presentation Differential Blood Pressure Effects of Ibuprofen, Naproxen, and Celecoxib in Patients with Arthritis August 30, 2017
Presentation ESC 2017 The Viborg Vascular (VIVA) Randomised Screening Trial Presenter: Jes Lindholt August 29, 2017
Presentation ESC 2017 Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation Presenter: Borja Ibanez August 28, 2017
Presentation ESC 2017 DETermination of the role of OXygen in suspected Acute Myocardial Infarction Presenter: Robin Hofmann August 28, 2017
Presentation ESC 2017 PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease Presenter: Martin J. Holzmann August 28, 2017
Presentation ESC 2017 Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial Presenter: Robert Giugliano August 28, 2017
Presentation ESC 2017 Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease Presenter: Paul M. Ridker August 27, 2017
Presentation ESC 2017 Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017
Presentation ESC 2017 Gender Differences in the Decrease of In-Hospital Mortality in Patients with Acute Myocardial Infarction Presenter: Dragana Radovanovic August 26, 2017